The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of weight change and BMI as prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in a Polish female cohort.
 
Malgorzata Pieniazek
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Gilead Sciences; Lilly; Novartis; Pfizer
 
Anna Polakiewicz-Gilowska
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer
Research Funding - Gilead Sciences; MSD; Novartis; Roche; Seagen
 
Manuela Las-Jankowska
Honoraria - Astellas Pharma
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi
 
Jakub Wronowicz
No Relationships to Disclose
 
Michal Jarzab
Honoraria - Novartis; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer
Speakers' Bureau - Exact Sciences; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Lilly; Pfizer; Roche
 
Aleksandra Lacko
No Relationships to Disclose
 
Marek Ziobro
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pierre Fabre
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche
 
Miroslawa Puskulluoglu
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Gilead Sciences; Janssen; Lilly; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Gilead Sciences; Novartis